← SynDRA
AGOMELATINE
SynDRA canonical compound SYN0000470 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | MTNR1B |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
| Indication | depression |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- MTNR1A
- HTR2C
- MTNR1B
- HTR2A
- HTR2B
- CYP1A2
- CYP2C19
Mechanisms of action (all sources)
- Melatonin receptor agonist
- Serotonin receptor antagonist
- MTNR1A AGONIST
- MTNR1B AGONIST
- HTR2C ANTAGONIST
- Serotonin 2c (5-HT2c) receptor antagonist
- HTR2A ANTAGONIST
- HTR2B ANTAGONIST
- MTNR1A FULL AGONIST
- MTNR1B FULL AGONIST
Drug classes
- Central Nervous System Agents
- Central Nervous System Depressants
- Hypnotics and Sedatives
ATC classes
Cross-references
Synonyms
- S20098
- S-20098
- valdoxan
- thymanax
- Agomelatina
- Thymanax
- Valdoxan
- Agomelatine [INN]
- AGO-178
- AGO178
- Agomelatine(INN)
- Valdoxan (TN)
- Valdoxan, Melitor, Thymanax, Agomelatine
- N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
- N-(2-(7-Methoxy-1-naphthalenyl)ethyl)acetamide
- N-(2-(7-Methoxynaphth-1-yl)ethyl)acetamide
- N-(2-(7-methoxy-1-naphthyl)ethyl)acetamide
- S 20098
- AGO 178
- N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
- DTXCID4031431
- agomelatinum
- RefChem:110192
- N06AX22
- N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetamide
- Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
- MFCD00916659
- N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide
- Agomelatine (INN)
- NCGC00253646-01
- Melitor
- N-[2-(7-Methoxynaphth-1-Yl)Ethyl]Acetamide
- Acetamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)-
- N-[2-(7-Methoxy-naphthalen-1-yl)-ethyl]-acetamide
- SR-01000944938
- Agomelatine [INN:BAN]
- AGO178C
- UNII-137R1N49AD
Look up AGOMELATINE in the interactive SynDRA portal →